SGTX
Sigilon Therapeutics, Inc. Common Stock
SGTX
SGTX
Delisted
SGTX was delisted on the 10th of August, 2023.
32 hedge funds and large institutions have $6.12M invested in Sigilon Therapeutics, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
32
Holding in Top 10
1
Calls
$9K
Puts
–
Top Buyers
| 1 | +$11.7K | |
| 2 | +$10.1K | |
| 3 | +$4K | |
| 4 |
Millennium Management
New York
|
+$477 |
| 5 |
BlackRock
New York
|
+$378 |
Top Sellers
| 1 | -$139K | |
| 2 | -$9K | |
| 3 | -$8.75K | |
| 4 |
Man Group
London,
United Kingdom
|
-$8K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$8K |